RS56122B1 - Inhibitori cdc7 - Google Patents
Inhibitori cdc7Info
- Publication number
- RS56122B1 RS56122B1 RS20170791A RSP20170791A RS56122B1 RS 56122 B1 RS56122 B1 RS 56122B1 RS 20170791 A RS20170791 A RS 20170791A RS P20170791 A RSP20170791 A RS P20170791A RS 56122 B1 RS56122 B1 RS 56122B1
- Authority
- RS
- Serbia
- Prior art keywords
- cdc7 inhibitors
- cdc7
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361782798P | 2013-03-14 | 2013-03-14 | |
US201361789108P | 2013-03-15 | 2013-03-15 | |
EP14712966.2A EP2970221B1 (en) | 2013-03-14 | 2014-03-07 | Cdc7 inhibitors |
PCT/US2014/021466 WO2014143601A1 (en) | 2013-03-14 | 2014-03-07 | CDC7 Inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
RS56122B1 true RS56122B1 (sr) | 2017-10-31 |
Family
ID=50382704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20170791A RS56122B1 (sr) | 2013-03-14 | 2014-03-07 | Inhibitori cdc7 |
Country Status (37)
Country | Link |
---|---|
US (1) | US9156824B2 (sr) |
EP (1) | EP2970221B1 (sr) |
JP (1) | JP6064079B2 (sr) |
KR (1) | KR101718645B1 (sr) |
CN (1) | CN105008351B (sr) |
AP (1) | AP2015008734A0 (sr) |
AU (1) | AU2014228374B2 (sr) |
BR (1) | BR112015020466B1 (sr) |
CA (1) | CA2900773C (sr) |
CL (1) | CL2015002530A1 (sr) |
CR (1) | CR20150416A (sr) |
CY (1) | CY1119199T1 (sr) |
DK (1) | DK2970221T3 (sr) |
EA (1) | EA027012B1 (sr) |
ES (1) | ES2639793T3 (sr) |
GT (1) | GT201500263A (sr) |
HK (1) | HK1212696A1 (sr) |
HR (1) | HRP20171151T1 (sr) |
HU (1) | HUE033482T2 (sr) |
IL (1) | IL240962B (sr) |
JO (1) | JO3383B1 (sr) |
LT (1) | LT2970221T (sr) |
ME (1) | ME02805B (sr) |
MX (1) | MX363438B (sr) |
MY (1) | MY188145A (sr) |
NZ (1) | NZ710392A (sr) |
PE (1) | PE20151654A1 (sr) |
PH (1) | PH12015502091A1 (sr) |
PL (1) | PL2970221T3 (sr) |
PT (1) | PT2970221T (sr) |
RS (1) | RS56122B1 (sr) |
SG (1) | SG11201507541PA (sr) |
SI (1) | SI2970221T1 (sr) |
TN (1) | TN2015000349A1 (sr) |
TW (1) | TWI622396B (sr) |
UA (1) | UA116125C2 (sr) |
WO (1) | WO2014143601A1 (sr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2906555T (pt) * | 2012-10-15 | 2017-02-15 | Pfizer Ireland Pharmaceuticals | Processo para a preparação de voriconazol e análogos do mesmo |
WO2014110574A1 (en) | 2013-01-14 | 2014-07-17 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
SG11201505347VA (en) | 2013-01-15 | 2015-08-28 | Incyte Corp | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
TWI627174B (zh) | 2013-03-14 | 2018-06-21 | 比利時商健生藥品公司 | P2x7調控劑 |
UY35391A (es) | 2013-03-14 | 2014-09-30 | Boehringer Ingelheim Int | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-cianometil)-amidas sustituidas inhibidores de catepsina c |
TWI599567B (zh) | 2013-03-14 | 2017-09-21 | 健生藥品公司 | P2x7調節劑 |
US10053463B2 (en) | 2013-03-14 | 2018-08-21 | Janssen Pharmaceutica Nv | Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators |
JP6294953B2 (ja) | 2013-03-14 | 2018-03-14 | ヤンセン ファーマシューティカ エヌ.ベー. | P2x7調節物質 |
US9556197B2 (en) | 2013-08-23 | 2017-01-31 | Incyte Corporation | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
WO2016010897A1 (en) | 2014-07-14 | 2016-01-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors |
HUE047208T2 (hu) | 2014-09-12 | 2020-04-28 | Boehringer Ingelheim Int | A katepszin-C spirociklikus inhibitorai |
EA034015B1 (ru) | 2014-09-12 | 2019-12-19 | Янссен Фармацевтика Нв | Модуляторы р2х7 |
US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
WO2017059251A1 (en) | 2015-10-02 | 2017-04-06 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
CN110036006B (zh) * | 2016-09-22 | 2022-12-13 | 癌症研究科技有限公司 | 嘧啶酮衍生物的制备和用途 |
WO2019113487A1 (en) | 2017-12-08 | 2019-06-13 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
CN108383771A (zh) * | 2018-01-08 | 2018-08-10 | 华东师范大学 | 手性3,3-二取代异吲哚啉-1-酮衍生物及其合成方法和应用 |
GB201807147D0 (en) | 2018-05-01 | 2018-06-13 | Oncologica Uk Ltd | Therapeutic combination |
NL2021185B1 (en) | 2018-06-26 | 2020-01-06 | Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis | Combination Therapy and Use Thereof for Treating Cancer |
TW202028198A (zh) | 2018-09-28 | 2020-08-01 | 比利時商健生藥品公司 | 單醯基丙三醇脂酶調節劑 |
BR112021005936A2 (pt) | 2018-09-28 | 2021-06-29 | Janssen Pharmaceutica Nv | moduladores de monoacilglicerol lipase |
US20220220125A1 (en) * | 2019-04-16 | 2022-07-14 | Janssen Pharmaceutica Nv | Fused isoindolin-1-one derivatives useful as grk2 inhibitors |
MX2022003819A (es) | 2019-09-30 | 2022-05-11 | Janssen Pharmaceutica Nv | Ligandos de pet de mgl radiomarcados. |
EP4126860A1 (en) | 2020-03-26 | 2023-02-08 | Janssen Pharmaceutica NV | Monoacylglycerol lipase modulators |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0400970D0 (sv) * | 2004-04-14 | 2004-04-14 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
TW200639163A (en) * | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
US7576082B2 (en) * | 2005-06-24 | 2009-08-18 | Hoffman-La Roche Inc. | Oxindole derivatives |
AU2007319580B2 (en) * | 2006-10-12 | 2012-11-29 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
US8648069B2 (en) | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
SG182187A1 (en) * | 2007-06-08 | 2012-07-30 | Abbott Gmbh & Co Kg | 5-heteroaryl substituted indazoles as kinase inhibitors |
-
2014
- 2014-03-04 JO JOP/2014/0067A patent/JO3383B1/ar active
- 2014-03-05 TW TW103107546A patent/TWI622396B/zh active
- 2014-03-07 UA UAA201508675A patent/UA116125C2/uk unknown
- 2014-03-07 AP AP2015008734A patent/AP2015008734A0/xx unknown
- 2014-03-07 EA EA201591509A patent/EA027012B1/ru not_active IP Right Cessation
- 2014-03-07 LT LTEP14712966.2T patent/LT2970221T/lt unknown
- 2014-03-07 DK DK14712966.2T patent/DK2970221T3/en active
- 2014-03-07 WO PCT/US2014/021466 patent/WO2014143601A1/en active Application Filing
- 2014-03-07 CN CN201480011202.4A patent/CN105008351B/zh active Active
- 2014-03-07 MY MYPI2015703062A patent/MY188145A/en unknown
- 2014-03-07 RS RS20170791A patent/RS56122B1/sr unknown
- 2014-03-07 PL PL14712966T patent/PL2970221T3/pl unknown
- 2014-03-07 JP JP2016500764A patent/JP6064079B2/ja active Active
- 2014-03-07 ES ES14712966.2T patent/ES2639793T3/es active Active
- 2014-03-07 HU HUE14712966A patent/HUE033482T2/en unknown
- 2014-03-07 SG SG11201507541PA patent/SG11201507541PA/en unknown
- 2014-03-07 BR BR112015020466-0A patent/BR112015020466B1/pt active IP Right Grant
- 2014-03-07 PT PT147129662T patent/PT2970221T/pt unknown
- 2014-03-07 ME MEP-2017-173A patent/ME02805B/me unknown
- 2014-03-07 EP EP14712966.2A patent/EP2970221B1/en active Active
- 2014-03-07 AU AU2014228374A patent/AU2014228374B2/en active Active
- 2014-03-07 CA CA2900773A patent/CA2900773C/en active Active
- 2014-03-07 MX MX2015012583A patent/MX363438B/es unknown
- 2014-03-07 US US14/200,141 patent/US9156824B2/en active Active
- 2014-03-07 PE PE2015001925A patent/PE20151654A1/es active IP Right Grant
- 2014-03-07 KR KR1020157024644A patent/KR101718645B1/ko not_active Application Discontinuation
- 2014-03-07 NZ NZ710392A patent/NZ710392A/en unknown
- 2014-03-07 SI SI201430280T patent/SI2970221T1/sl unknown
-
2015
- 2015-08-12 TN TN2015000349A patent/TN2015000349A1/en unknown
- 2015-08-14 CR CR20150416A patent/CR20150416A/es unknown
- 2015-08-31 IL IL240962A patent/IL240962B/en active IP Right Grant
- 2015-09-09 GT GT201500263A patent/GT201500263A/es unknown
- 2015-09-09 CL CL2015002530A patent/CL2015002530A1/es unknown
- 2015-09-14 PH PH12015502091A patent/PH12015502091A1/en unknown
-
2016
- 2016-01-21 HK HK16100636.2A patent/HK1212696A1/zh unknown
-
2017
- 2017-07-27 HR HRP20171151TT patent/HRP20171151T1/hr unknown
- 2017-08-10 CY CY20171100861T patent/CY1119199T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190373T1 (hr) | Inhibitori dnk-pk | |
HK1212696A1 (zh) | 抑制劑 | |
EP2968282A4 (en) | HISTONDEMENTHYLASEINHIBITOREN | |
PL3057959T3 (pl) | Inhibitory DNA-PK | |
HK1219475A1 (zh) | 腦啡肽酶抑制劑 | |
HK1216531A1 (zh) | 新的抑制劑 | |
IL245442A0 (en) | gsk–3 inhibitors | |
GB201305503D0 (en) | Inhibitor | |
GB201320835D0 (en) | HIF inhibitors |